The latest lymphoma news
All cells are important: A roadmap to characterise lymphoma stroma
Lymphomas are blood cancers that often start from lymph nodes. Lymph nodes contain not only…
Browsing: Lymphoma
AACR 2022: Natural killer cells complexed with a bispecific antibody may provide new treatment option for patients with advanced lymphoma
Natural killer (NK) cells derived from cord blood that were activated and complexed with a…
Axi-cel proves effective as first-line treatment for high-risk lymphoma
Results from the ZUMA-12 trial led by researchers at The University of Texas MD Anderson Cancer…
Key genomic alterations and potential therapeutic vulnerabilities identified in transformed cutaneous T-cell lymphoma
Cutaneous T-cell lymphoma (CTCL) is an incurable, rare cancer of skin-homing T cells that is highly…
Stem cell discoveries hold potential to improve cancer treatment
Two recent discoveries by stem cell scientists at Cedars-Sinai in the USA may help make…
Lymphoma: Key signaling pathway involved in tumour formation identified
There are myriad reasons why cancers develop. By studying genes which are altered in people…
Lymphoma cell metabolism may provide new cancer target
Diffuse large B cell lymphomas (DLBCLs) have a critical metabolic vulnerability that can be exploited…
Strange DNA structures may drive cancer development
Scientists at the La Jolla Institute for Immunology (LJI) in the USA have uncovered how…
Ibrutinib improves survival for younger people with diffuse large B-cell lymphoma
New evidence suggests that adding the targeted therapy ibrutinib (Imbruvica) to a standard chemotherapy regimen…
ASH 2021: ZUMA-7 demonstrates lasting benefits of CAR-T therapy over current standard of care for large B-cell lymphoma
Two-year data from the ZUMA-7 trial primary analysis show that the CAR T-cell therapy axicabtagene…